Skip to main content
AbbVieIntegration

Valkai partners with AbbVie to apply advanced AI in targeted areas of clinical development

What happened

AbbVie will deploy AI capabilities from Valkai to improve efficiency in targeted areas of clinical research.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Published on 09/29/2026 at 21:42 Contact us for any correction request AbbVie has increased its investments in artificial intelligence (AI) by entering into a new collaboration with Valkai to strengthen its integrated AI capabilities across clinical development. As part of this partnership with Valkai, AbbVie will deploy AI capabilities specifically designed to improve efficiency in targeted areas of clinical research, help teams produce analyses more quickly, and foster opportunities to reduce development timelines. This partnership with Valkai builds on the strong foundations established by AbbVie in applying AI to research and development (R&D), thereby helping to increase the scope of data-driven analyses and innovation.

ch.zonebourse.com/actualite-bourse/valkai-sa-associe-a-abbvie-pour-ap...Read the full source

Extracted by Autobound

From the Signal API record
Event
Integration

What this signalsA new integration often shows which tools the company builds around.

Product
AI capabilities

Companies

  • ValkaiPartnervalkai.com

More integration signals at other companies

The full record

From the Signal API record

Details

Release type
Feature

Topics and mentions

Product tags

  • online technology
  • general technology
  • future tech
  • data
  • medical

Extraction

Confidence
90%
Detected
Sep 29, 2026
signal_type
news
signal_subtype
integrates_with

Use this data

Get every integration signal for AbbVie and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”

  2. Send it to your own tools

    The Signal API returns integration signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/953583fd-fa76-646d-6295-090c4b7ff1ac returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.

{
  "signal_id": "953583fd-fa76-646d-6295-090c4b7ff1ac",
  "signal_type": "news",
  "signal_subtype": "integrates_with",
  "detected_at": "2026-09-29T19:42:51+00:00",
  "company": {
    "name": "AbbVie",
    "domain": "abbvie.com"
  },
  "data": {
    "url": "https://ch.zonebourse.com/actualite-bourse/valkai-sa-associe-a-abbvie-pour-appliquer-la-ia-avancee-dans-des-domaines-cibles-du-developpement-ce785ad2d98af02d",
    "title": "Valkai partners with AbbVie to apply advanced AI in targeted areas of clinical development - ch.zonebourse.com",
    "excerpt": "Published on 09/29/2026 at 21:42 Contact us for any correction request AbbVie has increased its investments in artificial intelligence (AI) by entering into a new collaboration with Valkai to strengthen its integrated AI capabilities across clinical development. As part of this partnership with Valkai, AbbVie will deploy AI capabilities specifically designed to improve efficiency in targeted areas of clinical research, help teams produce analyses more quickly, and foster opportunities to reduce development timelines. This partnership with Valkai builds on the strong foundations established by AbbVie in applying AI to research and development (R&D), thereby helping to increase the scope of data-driven analyses and innovation.",
    "product": "AI capabilities",
    "summary": "AbbVie will deploy AI capabilities from Valkai to improve efficiency in targeted areas of clinical research.",
    "planning": true,
    "image_url": "https://ch.zonebourse.com/images/twitter_ZB_fdblanc.png",
    "confidence": 0.9,
    "product_data": {
      "name": "AI capabilities",
      "full_text": "AI capabilities specifically designed to improve efficiency in targeted areas of clinical research",
      "fuzzy_match": false,
      "release_type": "feature"
    },
    "product_tags": [
      "online_technology",
      "general_technology",
      "future_tech",
      "data",
      "medical"
    ],
    "published_at": "2026-09-29T19:42:51Z",
    "article_sentence": "As part of this partnership with Valkai, AbbVie will deploy AI capabilities specifically designed to improve efficiency in targeted areas of clinical research, help teams produce analyses more quickly, and foster opportunities to reduce development timelines.",
    "related_company_name": "Valkai",
    "related_company_domain": "valkai.com"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.